@article{b814a32a8d914929a85446a518912502,
title = "Targeting PARP for Chemoradiosensitization: Opportunities, Challenges, and the Road Ahead",
author = "Henning Willers and Mechthild Krause and Corinne Faivre-Finn and Chalmers, \{Anthony J\}",
note = "Funding Information: This study was supported by the National Cancer Institute of the National Institutes of Health under Award Number U01CA220714 (HW, MK) and by a grant from the NIHR Manchester Biomedical Research Centre (CFF). Funding Information: Disclosures: H.W. and M.K. report research support from the National Cancer Institute of the National Institutes of Health, USA. C.F.F. reports research support from Cancer Research UK, AstraZeneca PLC, the National Institute for Health Research, UoLeeds, Yorkshire Cancer Research, and The Christie NHS Foundation Trust; and travel support from AstraZeneca and Elekta. A.J.C. reports research support from the Medical Research Council Research, Cancer Research UK Radiation Research Centre of Excellence, Children with Cancer UK, Chief Scientist Office (Scotland), AstraZeneca PLC , and honoraria from AstraZeneca PLC.",
year = "2022",
month = feb,
day = "1",
doi = "10.1016/j.ijrobp.2021.10.142",
language = "English",
volume = "112",
pages = "265--270",
journal = "International journal of radiation oncology, biology, physics",
issn = "0360-3016",
publisher = "Elsevier BV",
number = "2",
}